Auronis Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Patiala, Punjab, India, established in 2025.
2025 Patiala, Punjab, India Active
Last Updated:
Access Report
About Auronis Pharmaceuticals Private Limited

Auronis Pharmaceuticals Private Limited, a active private limited company, was established on 11 August 2025 in Patiala, Punjab, India. it holds CIN: U21002PB2025PTC065359. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Auronis Pharmaceuticals Private Limited. Its leadership includes Dharam Vir Garg (Director), Anil Kansal (Director), Himank Bansal (Director). It is based at D-280,, Industrial Focal Point, Patiala, Punjab, 147001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002PB2025PTC065359

  • Registration Number

    065359

  • Incorporation Date

    11 August 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Months 4 Days
Company report

Auronis Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Auronis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Auronis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dharam Vir Garg Director 11 Aug 2025 Current
Anil Kansal Director 11 Aug 2025 Current
Himank Bansal Director 11 Aug 2025 Current
Kashish Garg Director 11 Aug 2025 Current
Vikram Gupta Director 11 Aug 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Auronis Pharmaceuticals.
Auronis Pharmaceuticals revenue growth over time
Auronis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Auronis Pharmaceuticals?

Unlock access to Auronis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Auronis Pharmaceuticals?

Unlock and access historical data on people associated with Auronis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Auronis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auronis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Auronis Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Dharam Vir Garg was appointed as a Director was appointed as a Director on 11 Aug 2025 & has been associated with this company since 7 months 4 days . was documented.

  • Director Appointment

    Progress on Anil Kansal was appointed as a Director was appointed as a Director on 11 Aug 2025 & has been associated with this company since 7 months 4 days . was documented.

  • Director Appointment

    The activity Himank Bansal was appointed as a Director was appointed as a Director on 11 Aug 2025 & has been associated with this company since 7 months 4 days . was completed.

  • Director Appointment

    The activity Kashish Garg was appointed as a Director was appointed as a Director on 11 Aug 2025 & has been associated with this company since 7 months 4 days . was completed.

  • Director Appointment

    Vikram Gupta was appointed as a Director was appointed as a Director on 11 Aug 2025 & has been associated with this company since 7 months 4 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Auronis Pharmaceuticals Private Limited was registered on 11 Aug 2025 with Roc Chandigarh & aged 7 months 4 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Auronis Pharmaceuticals Private Limited?

The CIN of Auronis Pharmaceuticals Private Limited is U21002PB2025PTC065359.

Where is Auronis Pharmaceuticals Private Limited headquartered?

Auronis Pharmaceuticals Private Limited is headquartered at D-280,, Industrial Focal Point, Patiala, Punjab, 147001.

When was Auronis Pharmaceuticals Private Limited incorporated?

Auronis Pharmaceuticals Private Limited was incorporated on 11 August 2025.

Who are the current directors of Auronis Pharmaceuticals Private Limited?

The current directors of Auronis Pharmaceuticals Private Limited are

Is Auronis Pharmaceuticals Private Limited a listed company?

Auronis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Auronis Pharmaceuticals Private Limited?

The authorized capital of Auronis Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available